Rule 8 - (Cambridge)
April 02 2003 - 11:18AM
UK Regulatory
RNS Number:5745J
J.P. Morgan Securities Ltd
02 April 2003
FORM 8.1/8.3
Lodge with Company Announcements Office (which will publicise and copy
to the Panel).
Use separate form for each class of securities in which dealings have
been made.
Date of disclosure 2nd April 2003
DISCLOSURE UNDER RULES 8.1(a), 8.1(b)(i) AND 8.3
OF THE CITY CODE ON TAKE-OVERS AND MERGERS
Date of dealing 31st March 2003
Dealing in Cambridge Antibody Technologies Plc (name of company)
(1) Class of securities (eg ordinary shares) Ordinary Shares
(2) Amount bought
7,868
Amount Sold
0
Price per unit
350 p
(3) Resultant total of the same class owned or controlled
(and percentage of class) 7,868 ( 0.02 %)
(4) Party making disclosure J.P. Morgan Securities Limited
(5) EITHER (a) Name of purchaser/vendor (Note 1)
OR (b) If dealing for discretionary client(s), name of fund management
organisation
J.P. Morgan Securities Limited
(6) Reason for disclosure (Note 2)
(a) associate of (i) offeror (Note 3) YES
(ii) offeree company NO
Specify which category or categories of associate (1-8) 2
If category (8), explain
(b) Rule 8.3 (ie disclosure because of ownership or control of 1% or more
of the class of relevant securities dealt in) NO
Signed, for and on behalf of the party named in (4) above
(Also print name of signatory) Mukesh Halai
Telephone and extension number 020 7325 9925
This information is provided by RNS
The company news service from the London Stock Exchange
END
DCCUUUWGCUPWGMP